PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) EPS without NRI: Rp (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:DGNS PT Diagnos Laboratorium Utama Tbk ISX:DGNS
21 GF Score
Price Rp236.00
! 1 Warning Sign
View Full Analysis

What is PT Diagnos Laboratorium Utama Tbk EPS without NRI?

PT Diagnos Laboratorium Utama Tbk ISX:DGNS -1.67% 21 EPS without NRI is Rp as of . 20. GuruFocus rates ISX:DGNS with a GF Score™ of 21/100. The stock has 1 warning sign investors should review. Among 159 Medical Diagnostics & Research companies, PT Diagnos Laboratorium Utama Tbk ranks worse than 628930.19% on this metric.

PT Diagnos Laboratorium Utama Tbk's earnings per share without non-recurring items for the six months ended in . 20 was Rp0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for PT Diagnos Laboratorium Utama Tbk's EPS without NRI or its related term are showing as below:

ISX:DGNS's 3-Year EPS without NRI Growth Rate is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 10.8
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

PT Diagnos Laboratorium Utama Tbk's EPS (Diluted) for the six months ended in . 20 was Rp0.00.

PT Diagnos Laboratorium Utama Tbk's EPS (Basic) for the six months ended in . 20 was Rp0.00.


PT Diagnos Laboratorium Utama Tbk  (ISX:DGNS) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


PT Diagnos Laboratorium Utama Tbk EPS without NRI Related Terms


PT Diagnos Laboratorium Utama Tbk EPS without NRI Historical Data

* Premium members only.

The historical data trend for PT Diagnos Laboratorium Utama Tbk's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Diagnos Laboratorium Utama Tbk EPS without NRI Chart

PT Diagnos Laboratorium Utama Tbk Annual Data
Trend
EPS without NRI

PT Diagnos Laboratorium Utama Tbk Semi-Annual Data
EPS without NRI

ISX:DGNS vs TMO, DHR, IDXX: EPS without NRI Comparison

For the Diagnostics & Research subindustry, PT Diagnos Laboratorium Utama Tbk's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Diagnos Laboratorium Utama Tbk PE Ratio without NRI vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PT Diagnos Laboratorium Utama Tbk's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where PT Diagnos Laboratorium Utama Tbk's PE Ratio without NRI falls into.


ISX:DGNS
21GF Score
PT Diagnos Laboratorium Utama Tbk ISX:DGNS
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Diagnos Laboratorium Utama Tbk EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS without NRI for the trailing twelve months (TTM) ended in . 20 was Rp

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of Rp mean?
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) has a EPS without NRI of Rp as of . 20. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on PT Diagnos Laboratorium Utama Tbk and its competitors. According to the industry distribution chart, PT Diagnos Laboratorium Utama Tbk ranks #999999 out of 159 companies in the Medical Diagnostics & Research industry.
Is PT Diagnos Laboratorium Utama Tbk's EPS without NRI too high?
PT Diagnos Laboratorium Utama Tbk's current EPS without NRI is Rp. Based on the distribution chart, PT Diagnos Laboratorium Utama Tbk ranks #999999 out of 159 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, PT Diagnos Laboratorium Utama Tbk has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does PT Diagnos Laboratorium Utama Tbk's EPS without NRI compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Diagnos Laboratorium Utama Tbk ranks #999999 out of 159 companies for EPS without NRI. This places PT Diagnos Laboratorium Utama Tbk in the lower half of its industry. The industry median EPS without NRI is 10.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Diagnostics & Research company?
The median EPS without NRI among Medical Diagnostics & Research companies is 10.80, based on 159 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on PT Diagnos Laboratorium Utama Tbk and its competitors. For the Medical Diagnostics & Research industry, the median EPS without NRI is 10.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Diagnos Laboratorium Utama Tbk's current EPS without NRI is Rp. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diagnos Laboratorium Utama Tbk stock overvalued right now?
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) has a current EPS without NRI of Rp. The current EPS without NRI is Rp. PT Diagnos Laboratorium Utama Tbk's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For PT Diagnos Laboratorium Utama Tbk (ISX:DGNS), the current EPS without NRI is Rp as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Diagnos Laboratorium Utama Tbk Business Description

Address Jl. Cikditiro No. 11 A, B, C, Gedung Graha Anam Lantai 2, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350
PT Diagnos Laboratorium Utama Tbk operates in the field of Health Support Services and Private Clinic Activities. It provides health support service activities managed by both the government and the private sector, such as health laboratories in the form of X-Ray Laboratories, and other diagnostic imaging centers, as well as blood testing, private clinics, pharmaceutical warehouses, eye banks, blood banks, sperm banks, organ transplant banks, and other medical support services. Its products and services include Clinical Pathology Laboratory, Anatomical Pathology Laboratory, Genomics Laboratory, Homecare Health Services, Corporate Health Services, Microbiology Laboratory, and Research Services.
21GF Score

Get the complete analysis for ISX:DGNS

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp236.00
Price